March 6, 2023 — More than 80% of U.S. adults with type 2 diabetes meet the criteria to use new treatment drugs, such as semaglutide, which is marketed…
Read more 80% With Diabetes Eligible for New Drugs, but Cost Is a BarrierBram Sable-Smith and Samantha Young When drugmaker Eli Lilly announced Wednesday it will slash the list price for some of its insulin products following years of criticism from…
Read more Eli Lilly Slashed Insulin Prices. This Starts a Race to the Bottom.Feb. 15, 2023 — Gene therapies have the power to cure serious, even fatal, diseases. Yet what captures public attention is often not the transformative effects but the…
Read more Is $3.5 Million a Fair Price for a Lifesaving Gene Therapy?Oct. 26, 2022 – Trapper Haskins, a 45-year-old musician with type 1 diabetes, says the price of insulin is a constant stressor in his life. The Nashville resident…
Read more Biosimilars May Finally Stop the Rocketing Cost of Insulin
